Ursodeoxycholic acid is a medication used in the management and treatment of cholestatic liver disease. This activity reviews the indications, mechanism of action, and contraindications for UDCA as a valuable agent in managing liver disease. This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the interprofessional team performing patient management of cholestatic liver disease and related conditions.

**Objectives:**
- Identify the mechanism of action of ursodeoxycholic acid.
- Describe the potential adverse effects of ursodeoxycholic acid.
- Review appropriate monitoring needed for patients receiving therapy with ursodeoxycholic acid.
- Explain interprofessional team strategies for improving care coordination and communication to advance the use of ursodeoxycholic acid and improve outcomes.